Navigation Links
Investigating the development of mechanosensitivity
Date:5/22/2009

Researchers of the Max Delbrck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have gained crucial insight into how mechanosensitivity arises. By measuring electrical impulses in the sensory neurons of mice, the neurobiologists and pain researchers Dr. Stefan G. Lechner and Professor Gary Lewin were able to directly elucidate, for the first time, the emergence of mechanosensitivity. At the same time they were able to show that neurons develop their sensitivity to touch and pain during different developmental phases but always coincidentally with the growth of the neuronal pathways. (EMBO Journal, 2009, doi:10.1038/emboj.2009.73).*

The sensory neurons, which are sensitive to touch and pain, are located in the dorsal root ganglia between the intervertebral discs. The neurons receive the stimulus and convert it into electrical signals that are conveyed to the brain.

Signal transduction has been investigated very thoroughly, which has led to the development of drugs that block the transduction of pain signals to the brain. Very little, however, is known about how stimulus sensitivity actually emerges.

Using the patch-clamp technique in isolated cells of mouse embryos, the MDC researchers succeeded in measuring tiny electrical currents in the cell membranes after a mechanosensory stimulus.

"These measurements are extremely difficult," Dr. Lechner explained, "which is why only very few laboratories in the world are specialized in this area."

The researchers in Berlin-Buch were able to show that the sensory neurons in the mouse embryo have already fully developed their mechanosensitivity competence on embryonic day 13. That corresponds to about the end of the sixth month of pregnancy in humans.

For this development the neurons do not require any nerve growth factor, which is why the researchers suspect that this process is driven by a genetic program. In contrast, the competence to sense pain in
'/>"/>

Contact: Barbara Bachtler
bachtler@mdc-berlin.de
49-309-406-3896
Helmholtz Association of German Research Centres
Source:Eurekalert

Page: 1 2

Related biology news :

1. Strong immune response to new siRNA drugs in development may cause toxic side effects
2. Development of an artificial simulator of the nervous system to do research into diseases
3. ExcellGene and Khner achieved milestone in development of novel 250 Liter mammalian cell culture bioreactors
4. Beating heart machine expedites research and development of new surgical tools, techniques
5. $1.6 million grant to lead development of resistance-detecting field kit
6. NIH grants $122 million in Institutional Development Awards
7. Bovine genome provides clues to possible new developments
8. Researchers discover that gene switches on during development of epilepsy
9. Mouse model provides a new tool for investigators of human developmental disorder
10. Prenatal meth exposure linked to abnormal brain development
11. NIH funds development of resistance-breaking insecticides to reduce malaria transmission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... September 23, 2014 A new American Cancer Society ... Assistance Program (SNAP), previously known as the food ... with income eligible non-participants. The authors say the ... at enhancing the dietary quality of SNAP participants. ... individuals and households with the resources to obtain ...
(Date:9/22/2014)... researchers are studying a potential new treatment that reverses ... which scars develop in the lungs and severely hamper ... which is delivered to lung tissue intravenously. In mouse ... fibrosis after several days. , The findings were ... Medicine . , "The mimic, when injected into the ...
(Date:9/22/2014)... genetic sequencing technologies continue to evolve rapidly, becoming part ... establish appropriate policies and regulatory frameworks to address potential ... policy issue of the Journal of Law, Medicine ... experts with the Center for Medical Ethics and Health ... the tools to jumpstart this process. , Experts ...
Breaking Biology News(10 mins):Federal food program puts food on the table, but dietary quality could be improved 2Reversing the effects of pulmonary fibrosis 2Experts provide much-needed policy analysis for clinical integration of next generation sequencing 2Experts provide much-needed policy analysis for clinical integration of next generation sequencing 3
... Director,s T-R01 Award , Speedier Lab Testing With Results ... associate professor of pharmacology at Weill Cornell Medical College, ... NIH Director,s Transformative R01 award from the National Institutes ... innovative protein recognition technologies that may some day speed ...
... Fisher, associate professor in the Fischell Department of Bioengineering, ... Research and Technology Review Day with a tissue engineering ... tissue for implantation. Fisher,s technology was one of ... faculty members and graduate students at the Professor Venture ...
... Researchers have shown how an experimental drug might restore ... by preventing short circuits caused when tiny "potassium channels" ... also might be developed as a treatment for multiple ... a common type of spinal cord trauma, called "compression" ...
Cached Biology News:Weill Cornell science briefs: November 2009 2Weill Cornell science briefs: November 2009 3Weill Cornell science briefs: November 2009 4Weill Cornell science briefs: November 2009 5Bioreactor for bone tissue engineering wins professor venture fair 2Bioreactor for bone tissue engineering wins professor venture fair 3Drug studied as possible treatment for spinal injuries 2Drug studied as possible treatment for spinal injuries 3
(Date:9/23/2014)... For the fifth time since 2006, ExakTime has been ... fastest-growing companies. , “We’re so proud that ExakTime’s rapid and ... ExakTime CEO Tony Pappas said. , ExakTime earned its ranking ... rate of 61 percent from 2010 to 2013 and by ... percent. , Pappas cited strong performance in the construction market ...
(Date:9/23/2014)... 23, 2014 News Facts ... devoted to genome-based research for human health and ... is taking a bite out of oral cancer with its ... India with the help of state-of-the-art ... Networks (DDN). , To fuel its cutting-edge cancer research, ...
(Date:9/23/2014)... September 23, 2014 Equashield ... Transfer     Devices  (CSTD) for hazardous ... MedFront Medical Technology Corporation.  Equashield,s leading CSTD has ... Taiwan , China ... continues to expand globally, and throughout the ...
(Date:9/23/2014)... Plymouth, MN (PRWEB) September 23, 2014 ... named NimbeLink, a developer of cellular modems ... a finalist in the Startup category for the ... will be held at the Minneapolis Convention Center ... Minnesota companies and individuals who have shown superior ...
Breaking Biology Technology:ExakTime Makes Inc. 5000 List for the Fifth Time 2National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 2National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 3National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 4National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 5Equashield Enters Taiwan Following Expansion to Australia, Japan, China 2NimbeLink Named Finalist for 15th Annual Tekne Awards 2NimbeLink Named Finalist for 15th Annual Tekne Awards 3
... Simbionix,the world,s leading developer of medical simulation systems, ... a global collaboration,agreement. Simbionix will exclusively distribute, market, ... virtual reality hysteroscopy simulator. , ... simulators for minimal,invasive surgery. "This new agreement further ...
... Put in Place to Serve Future Requirements of Stem ... SIAL ) today announced the launch of an ... to its extensive portfolio of industry-leading products developed specifically ... over 1,100 unique and highly-focused products that are expected ...
... All amounts are in U.S. dollarsQUEBEC CITY, March 11 /PRNewswire-FirstCall/ - ... Company"), a global biopharmaceutical company focused on endocrinology and oncology, today ... full year ended December 31, 2008., 2008 Highlights, ... First patients treated with AEZS-108 for a Phase 2 trial in ...
Cached Biology Technology:Simbionix Increases Product Offerings for OB/GYN Physicians 2Sigma-Aldrich Streamlines Access to Advanced Stem Cell Research Portfolio and Opens Stem Cell Biology Community Through New Web Portal 2Sigma-Aldrich Streamlines Access to Advanced Stem Cell Research Portfolio and Opens Stem Cell Biology Community Through New Web Portal 3AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 2AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 3AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 4AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 5AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 6AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 7AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 8AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 9AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 10